Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Second Quarter 2024 Conference Call. At this time, participants are in a listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Armistice Capital Steven Boyd | 7,917,653 | $2,680,126 | 0.03% | |
2. | Ikarian Capital Neil Shahrestani | 90,242 | $30,547 | 0% | |
3. | 40,000 | $13,540 | -21% | 0% | |
4. | 7,200 | $2,437 | +800% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.52 | 15,000 | Officer | 1,164,865 | 2024-05-28 | Filing | |
$0.64 | 25,000 | Officer | 1,149,865 | 2024-05-22 | Filing | |
$0.58 | 25,000 | Officer | 1,124,865 | 2024-05-21 | Filing | |
$0.49 | 10,000 | Officer | 1,099,865 | 2024-05-13 | Filing | |
$0.47 | 10,000 | Officer | 1,089,865 | 2024-05-11 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.35 | 63,000 | Officer | 0 | 2024-07-19 | Filing | |
$13.47 | 7,823 | Other | 67,053 | 2020-07-16 | Filing | |
$13.12 | 18,430 | Other | 74,876 | 2020-07-15 | Filing | |
$13.52 | 40,000 | Other | 93,306 | 2020-07-13 | Filing | |
$13.35 | 2,000 | Other | 133,306 | 2020-07-10 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 1,423,310 | $388,564 | 0% | |
2. | 466,355 | $127,316 | 0% | |
3. | 357,041 | $97,512 | 0% | |
4. | 199,356 | $54,424 | 0.02% | |
5. | 115,785 | $31,609 | 0% |